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Abstract
Cationic liposomes are useful to transfer genes into eukaryotic cells in vitro and in vivo. However, liposomes with good
transfection efficiency are often cytotoxic, and also require serum-free conditions for optimal activity. In this report, we
describe a new formulation of cationic liposome containing DC-6^14, O,OP-ditetradecanoyl-N-(K-trimethylammonioace-
tyl)diethanolamine chloride, dioleoylphosphatidylethanolamine and cholesterol for gene delivery into cultured human cells.
This liposome, dispersed in 5% serum-containing growth medium, efficiently delivered a plasmid DNA for GFP (green
fluorescent protein) into more than 80% of the cultured human cell hybrids derived from HeLa cells and normal fibroblasts.
Flow cytometric analysis revealed that the efficiency of the GFP gene expression was 40^50% in a tumor-suppressed cell
hybrid, while it was greatly reduced in the tumorigenic counterpart. The enhanced GFP expression in tumor-suppressed cell
hybrids was quantitatively well correlated with a prolonged presence of the plasmid DNA, which had been labeled with
another fluorescent probe, ethidium monoazide, within the cells. These results suggest that a newly developed cationic
liposome is useful for gene delivery in serum-containing medium into human cells and the stability of the plasmid DNA
inside the cell is a crucial step in this liposome-mediated gene expression. The mechanisms by which cationic liposome
mediates gene transfer into eukaryotic cells are also discussed. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Since gene delivery has possible applications in
gene therapy for various human diseases such as ge-
netic disorders and cancer, attention has been mainly
focused on developing e⁄cient and adequate gene
delivery systems as well as on elucidating the mech-
anisms involved in the transfer of genes into cells [1^
5]. Much work has been done on delivery systems
which utilize a viral or cationic liposomal vector.
As vectors, attenuated or defective viruses provide
for e⁄cient gene delivery into many cells and tissues
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[4,5]. However, they have serious drawbacks includ-
ing risk of recombination and strong immunogenic-
ity. Cationic liposomes, in contrast, possess many
physical characteristics that make them attractive as
candidates for gene delivery vectors [1^3,6]. For ex-
ample, cationic liposomes have proven safe on re-
peated in vivo use. In addition, they are suitable
for ex vivo protocols. A major limitation with cati-
onic liposomes however, is their low e⁄ciency in
transgene expression and their toxicity, although
many improvements in cationic lipids and liposome
preparations containing DNA have been made
[1,3,7]. The presence of serum often reduces the
transfection e⁄ciency of liposomal vectors. Several
new cationic liposomes useful for serum-containing
media have recently been developed [1,3,8]. However,
some of them are provided by commercial compa-
nies, thus their use in mechanism analysis as well as
the modulation of formulations is limited.
Previously, Kikuchi, et al. [9] have reported a ser-
ies of new cationic liposomes containing O,OP-di-
tetradecanoyl-N-(K-trimethylammonioacetyl)-dietha-
nolamine chloride (DC-6^14), which have transgene
activities in serum-containing medium for human
peritoneal disseminated tumors both in vitro and in
vivo. However, most of the results are based on qual-
itative analysis and the activities are varied in their
formulations. Thus, factors which control the trans-
gene activity by these liposomes remain largely un-
known. In the present report, we further describe
that one of these new liposomes composed of DC-
6^14, DOPE and cholesterol in molar ratio of 4:3:3,
e⁄ciently promotes gene delivery with serum into
HeLa-derived human cell hybrids, whose in vivo tu-
morigenicity may be controlled by a putative tumor
suppressor gene on chromosome 11, and the paired
combinations of non-tumorigenic and tumorigenic
HeLa-derived cell hybrids allow the characterization
of cellular changes genetically linked to this putative
tumor suppressor function [10^12]. Quantitative
analysis of the transgene expression induced by this
cationic liposome using this cell hybrid system with
two independent £uorescent probes, green £uores-
cent protein (GFP) and ethidium monoazide
(EMA), suggested that di¡erence in the e⁄ciency
of the GFP gene expression between human cell
hybrids through this liposome vector is well con-
sistent with the stability of the plasmid DNA within
the cells. Characteristics of this new cationic lipo-
some are discussed in comparison with other cationic
liposomal vectors for gene delivery in vitro and in
vivo.
2. Materials and methods
2.1. Chemicals
A humanized (Ser-65 to Thr converted) GFP plas-
mid, pGreenLantern-1 (pGL-1), with cytomegalovi-
rus promoter was purchased from Gibco-BRL. The
plasmids grown in Escherichia coli were puri¢ed with
a Qiagen kit (Qiagen, Hilden, Germany), diluted in
distilled water at about 1^2 Wg/ml, and stored at
320‡C. A £uorescent probe, ethidium monoazide
(EMA, Molecular Probes, Eugene, OR) can be pho-
tolysed in the presence of nucleotides to yield £uo-
rescently labeled nucleic acids. After its photo-cross-
linking to nucleic acids, EMA sends out red
£uorescence (600 nm) at a similar wavelength (464
nm) as GFP [13,14]. An approximately 4.76 mM
EMA solution and pGL-1 plasmid were used for
photolysis. Samples with a 50:1 molar ratio of nu-
cleotide to EMA were individually prepared. After
15 min incubation on ice, photolysis was performed
with Sunlamp (Funakoshi, Tokyo, Japan) equipped
with a mercury lamp, which had spikes of high emis-
sion in its output including a spike at about 370 nm.
Samples were then irradiated for 30 min by Sunlamp.
To remove intercalated but not covalently bound
EMA after photolysis, the ethanol precipitation and
washing were repeated three times [15]. The £uores-
cently labeled plasmid in the bottom layer was dis-
solved in 100 Wl of distilled water and stored at
320‡C. The GFP protein with 238 amino acids sta-
bly emits green £uorescence at 511 nm when the ex-
citation wavelength is 488 nm [16].
A cationic lipid, O,OP-ditetradecanoyl-N-(K-trime-
thylammonioacetyl)diethanolamine (DC-6^14) was
purchased from Sogo (Tokyo, Japan). L-K-Dioleoyl-
phosphatidylethanolamine (DOPE) and cholesterol
were purchased from NOF (Tokyo, Japan) and
Sigma (St. Louis, MO, USA), respectively. All other
chemicals were of commercial analytical grade.
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2.2. Cell culture
The human cell hybrids, CGL1 (non-tumorigenic)
and CGL4 (tumorigenic), were derived from the fu-
sion of a HeLa cell line D98/AH2 with a diploid
normal human ¢broblast line GM77, which had
been established by Stanbridge et al. [10]. These cells
were grown in Dulbecco’s modi¢ed Eagle’s medium
(DMEM, Flow Laboratories, MA) supplemented
with 5% (v/v) fetal bovine serum (FBS, Flow Labo-
ratories), penicillin (100 U/ml) and streptomycin (100
Wg/ml). Cultures were maintained in 100-mm plastic
dishes (Corning, NY) at 37‡C in a 5% CO2/95% air
incubator, as described previously [12]. These cells
were free from Mycoplasma contamination.
2.3. Cationic liposome preparation and transfection
Liposomes were prepared by the method of freeze-
dried empty liposomes (FDELs), as described previ-
ously [9]. Brie£y, DC-6^14, DOPE and cholesterol
were dissolved in a chloroform^methanol mixture
(4:1, v/v), and the solvent was removed in a rotary
evaporator. After mixing of the lipids with 9% su-
crose aqueous solution, they were hydrated at 60^
70‡C and homogenized. To obtain a homogeneous
vesicle size distribution, the dispersion was extruded
twice at 60^70‡C through a polyvinylidenedi£uoride
membrane ¢lter with 0.22 Wm pore size by using Li-
ponizer LP-90 (Nomura Micro Science, Kanagawa,
Japan). The dispersion was pipetted into glass vials
(0.5 or 2 ml portion each), frozen at 350‡C for 4 h
and then lyophilized in a freeze-drier (Virtis, New
York, USA). The dried liposomes were then recon-
stituted with 0.5 or 2 ml of distilled water by a gentle
mixing prior to transfection.
To investigate the gene expression or transfer e⁄-
ciency, the cells were seeded at a density of 1U105 on
6-well plates (Corning-Coaster, Tokyo, Japan) or 35
mm glass-base dishes (Iwaki Scitech, Japan) with 2 ml
of DMEM containing 5% FBS and incubated for 18^
24 h at 37‡C in 5% CO2. One hundred microliters of
serum-free DMEM or Opti-MEM (Gibco-BRL) con-
taining an appropriate amount of pGL-1 were mixed
with 100 Wl of serum-free DMEM containing appro-
priate amount of TFL-08 or 100 Wl of Opti-MEM
containing 6 Wg of Lipofectamine (Gibco-BRL) with
mild agitation in polystyrene tubes and incubated for
15 min at room temperature. Prior to transfection,
cells were washed with serum-free DMEM and
added to 800 Wl of DMEM containing 6.25% FBS,
serum-free DMEM or Opti-MEM. Then 200 Wl of
complex solution (a ¢nal volume of 1 ml and ¢nal
concentration of 5% FBS or free of serum) was
added. After 5 h incubation at 37‡C, the old medium
was removed, the cells were washed twice with se-
rum-free DMEM, 2 ml of DMEM containing 5%
FBS was added and the culture was continued for
19 h.
2.4. Electron microscopy of cationic liposome^DNA
complex
A negative staining technique was used for elec-
tron microscopic analysis of the liposome^DNA
complex. A drop of complex indicated in the text
was placed on a 300 mesh copper grid, and the excess
solution was absorbed with a ¢lter paper. A drop of
2% phosphotungstic acid solution was then placed
on the grid. This grid was then dried for 5 min under
ambient conditions before microscopic analysis. The
micrographs of complex were recorded using a trans-
mission electron microscope (Hitachi H-500).
2.5. Analysis by £uorescence microscopy and FACS
To evaluate gene expression e⁄ciency, we used
£uorescent microscopy (Diaphoto-TMD, Nikon).
The GFP-expressing cells were visualized under the
£uorescent microscope without ¢xation. The green-
colored cells in a culture were enumerated and the
percentage of the total cell population was calcu-
lated. We also used a £uorescein activated cell sorter
(FACS, Becton-Dickinson) equipped for £uorescein
isothiocyanate detection at an excitation wavelength
of 488 nm (an argon laser). The £uorescence inten-
sity of individual cells was measured as relative £uo-
rescence units (RFU). Transfected cells were har-
vested by incubation with 0.3 ml of 0.25% trypsin
and 0.02% EDTA. After incubation, 1 ml of
DMEM containing 5% FBS was added and cells
were ¢xed with 1 ml of 4% paraformaldehyde
(PFA, Wako, Osaka, Japan) for 30 min at 4‡C. After
centrifugation at 1000 rpm for 5 min, the superna-
tant was discarded and the ¢xed cells were then
rinsed with 2 ml of phosphate-bu¡ered solution
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(PBS, Gibco-BRL) by centrifugation at 1000 rpm for
5 min. The ¢nal pellet was resuspended in 1 ml of
PBS containing 0.05% sodium azide and 2 mM
EDTA/2Na and delivered to 12U75-mm glass tubes.
The £uorescence from approximately 10 000 individ-
ual cells collected as list-mode data, which consisted
of forward and side scatter, was analyzed (Lysis soft-
ware, Becton-Dickinson). The percentage of GFP-
positive cells was calculated by determining the per-
centage of highly £uorescent cells with £uorescence
emission centered at 530 nm (FL1) and subtracting
the £uorescence of control cells that were exposed to
the liposome only with a standard gating technique.
No electric compensation was performed in these
experiments.
2.6. Confocal laser scanning microscopy of the
plasmid DNA labeled with a £uorescent probe
To determine the percentages of cells in which £u-
orescently labeled plasmid had entered, we used a
confocal laser scanning microscope (Micro Systems
LSM 410, Carl Zeiss, Germany). The plasmid labeled
with EMA was most e⁄ciently excited using 488 nm
illumination and detected by an LP590 ¢lter. Trans-
fected cells were ¢xed immediately after transfection
at the indicated times (0.5, 1, 2, 4, 8, 12 and 24 h) to
retain £uorochrome within the cells. At 0.5, 1, 2 and
4 h after transfection, the cells were thoroughly
washed with PBS three times to remove extracellular
or membrane-bound plasmid and ¢xed with 1 ml of
4% PFA for 30 min at 4‡C. Then the cells were
rinsed with PBS three times for 10 min at 4‡C and
enclosed with 1 ml of 80% glycerol (Merck, Ger-
many). At 5 h after transfection, the old medium
was removed, the cells were washed twice with se-
rum-free DMEM, 2 ml of DMEM containing 5%
FBS was added and the mixture was cultured further
at 37‡C. At 8, 12 and 24 h after transfection, the cells
were ¢xed and enclosed as described above. In each
experiment, samples were prepared in triplicate for
this determination.
3. Results
3.1. Flow cytometric analysis of gene transfer
mediated by a new cationic liposome containing
DC-6^14, DOPE and cholesterol
Since one of the most obvious problems with using
cationic liposomes in a gene-delivery system is a low
transfection e⁄ciency in serum-containing medium,
we have synthesized and tested a series of cationic
liposomes which display good lipofection e⁄ciency
for cultured cells in the presence of serum. As re-
ported previously [9], most of these initial screenings
were evaluated qualitatively based on the transfec-
tion e⁄ciency of the transgene product in the whole
cell lysate as units/protein amount. From these stud-
ies, we have selected a potential formulation com-
posed of DC-6^14, DOPE and cholesterol in the
molar ratio 4:3:3, which is now termed TFL-08.
As shown in Fig. 1, DC-6^14 is an N-K-trimeth-
yl(ammonioacetyl)diethanolamine chloride having
two acyl chains. It is an analogue of a cationic lipo-
somal component, TMAG, which is N-(K-trimethyl-
ammonoacetyl)didodecyl-D-glutamate chloride [6].
Fig. 1. Chemical structure of DC-6^14, O,OP-ditetradecanoyl-N-
(K-trimethylammonioacetyl)diethanolamine chloride.
C
Fig. 2. GFP expression induced by DC-6^14 liposome (TFL-08). A tumorigenic HeLa cell hybrid CGL4 was transfected by the GFP
plasmid (pGL-1, 1 Wg) complexed with a cationic liposome TFL-08 (8 nmol as the total amount of lipids) in 5% serum-containing me-
dium and the expression was monitored by £uorescent microscopy (A-1). The same ¢eld was also photographed by phase-contrast mi-
croscopy (A-2). E⁄ciencies of the transgene expression through TFL-08 liposome were analyzed by FACS as follows: (B-1) liposome
alone in CGL4 cells ; (B-2) liposome+pGL-1 in CGL4 cells ; (C-1) liposome alone in CGL1 cells ; (C-2) liposome+pGL-1 in CGL1
cells. In D, a correlation between FACS and £uorescent microscopic analyses is shown. Transfection of pGL-1 into CGL4 cells was
performed with various amounts of TFL-08 (2.5^25 nmol) in 5% serum-containing medium and e⁄ciencies of GFP expression were
analyzed by FACS and £uorescent microscopy respectively, then were scatterplotted. r, value of correlation coe⁄cient.
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Unlike TMAG-liposomes or other commercially
available liposomes, such as Lipofectamine (Gibco-
BRL), TFL-08 contains cholesterol.
To examine the transfection e⁄ciency quantita-
tively on a cellular basis, we have analyzed TFL-
08-mediated gene transfer of the GFP plasmid into
a tumorigenic HeLa-derived cell hybrid, CGL4, as a
target. Fluorescent microscopy revealed that GFP
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was expressed in these cells when transfected with
TFL-08, but not in the absence of this liposome
(Fig. 2A). When this GFP expression in CGL4 cells
was monitored by FACS, as little as 10% of the cells
were shown to be positive for GFP expression (Fig.
2B). In contrast, a more e⁄cient GFP expression
with TFL-08, as much as 45% of the cell population,
was observed in the tumor-suppressed HeLa-cell hy-
brid, CGL1 (Fig. 2C). The transfection e⁄ciencies of
the GFP gene with varied amounts of TFL-08 moni-
tored by FACS were quantitatively well correlated
with those by £uorescent microscopy (Fig. 2D).
3.2. Optimal conditions for liposome-mediated GFP
expression
Since a relatively high transgene expression of
GFP through TFL-08 liposome was obtained with
CGL1 cells, optimal conditions were further exam-
ined by FACS. As shown in Fig. 3, expression of the
GFP gene in CGL1 cells was dependent on the plas-
mid DNA as well as cationic liposome TFL-08 added
to the medium containing 5% fetal bovine serum.
Similar results were obtained when 10% fetal bovine
serum was added to the medium (data not shown).
The cationic liposome at 8 nmol (3.2 nmol as a cat-
ionic DC-6^14) e⁄ciently delivered 0.5^1.5 Wg of the
plasmid DNA into the cells (Fig. 3A). The molecular
weight of a nucleotide is about 330 Da and hence
1 Wg of pGL-1 plasmid should have about 3 nmol of
negatively charged molecules. Based on this estima-
tion, charge ratio (3/+) of the plasmid DNA to cat-
ionic lipid was indicated in Fig. 3, demonstrating
that the charge ratios around neutral range were
most e¡ective.
The transgene expression was evident within 5 h
Fig. 3. Optimal conditions for gene transfer by TFL-08 lipo-
some. (A) CGL1 cells were transfected with various amounts of
pGL-1 and 8 nmol of TFL-08 in serum-containing medium and
GFP expression was analyzed at 24 h after transfection by
FACS. (B) Both CGL1 cells and CGL4 cells were similarly
transfected with 1 Wg of pGL-1 in the presence of the indicated
amount of TFL-08 and the e⁄ciencies of the GFP gene expres-
sion were determined as described in A. The estimated charge
ratios of pGL-1 to TFL-08 liposome used in transfection were
given as (3/+).
Fig. 4. E¡ect of serum on transgene expression by cationic lipo-
somes. The expression of pGL-1 gene in CGL1 cells through ei-
ther Lipofectamine (6 Wg) or TFL-08 (8 nmol) in the absence
(dotted bars) or presence of 5% fetal bovine serum (hatched
bars) was determined by FACS. Results are the mean+S.D.
from three or six separate experiments for Lipofectamine and
TFL-08, respectively.
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after lipofection in both CGL1 and CGL4 cells, lead-
ing to a maximum expression after transfection for
20^24 h, followed by a gradual decline (data not
shown). For 1 Wg of plasmid DNA, as low as 2.5
nmol TFL-08 in a charge ratio (3/+) of 1/0.31 was
able to deliver the GFP gene into cells with a peak of
expression observed at 8 nmol, and a decrease at
higher amounts of the liposome (Fig. 3B). This
may be partly due to cell damage by this liposome
even in the presence of 5% serum, since cell viability
Fig. 5. Electron photomicrographs of cationic liposome^plasmid complex. TFL-08 liposome (8 nmol) was mixed with pGL-1 (1 Wg/
ml) in DMEM in the presence (C, 15 min; D, 1 h) or absence (B, 15 min) of 5% fetal bovine serum. Then, electron photomicrographs
were taken as described in Section 2. An electron photomicrograph of TFL-08 liposome (8 nmol) alone in DMEM for 15 min is
shown in (A). Electron photomicrographs of Lipofectamine (6 Wg) complexed with pGL-1 (1 Wg/ml) in DMEM were taken after incu-
bation for 15 min in the presence (F) or absence (E) of 5% fetal bovine serum.
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determined by [3H]thymidine uptake at more than 25
nmol TFL-08 was 30^50% of the untreated cell val-
ue, while at 5^10 nmol, the viability was kept at
more than 80%.
3.3. E¡ect of serum on TFL-08-mediated gene
transfer
Serum often reduces cationic liposome-mediated
gene expression in eukaryotic cells [1^3]. As shown
in Fig. 4, the transfection activity of the cationic
liposome, Lipofectamine, in CGL1 cells was mark-
edly reduced in 5% serum-containing medium. In
contrast, the TFL-08-induced GFP expression in
CGL1 cells was higher in 5% serum-containing me-
dium than in serum-free medium. This serum e¡ect
on cationic lipofection was not obvious in tumori-
genic CGL4 cells probably due to the reduced e⁄-
ciency of the transgene expression (8^10%) in the
presence of serum.
3.4. Electron microscopy of TFL-08 liposome
One characteristic of TFL-08 liposome possessing
enhanced gene delivery activity in the presence of
serum may be its spherical structure in the medium,
since preliminary studies by electron microscopy
found that the typical spherical structure of several
cationic liposomes was often lost in serum-containing
medium. Vesicular structures of TFL-08 liposome
dispersed in serum-free medium was shown in Fig.
5A. When this liposome was mixed with the GFP
plasmid in serum-free medium at the concentrations
used for transfection, large aggregates in spherical
and granular form were observed (Fig. 5B). In 5%
serum-containing medium as used for transfection,
this cationic liposome^DNA complex formed rather
smaller and uniform vesicular structures with a diam-
eter of 100^200 nm (Fig. 5C), and these vesicular
structures were stably maintained for 1 h after the
formation of complex (Fig. 5D) and were seen for at
least 6 h (data not shown). In contrast, the spherical
structure of Lipofectamine seen in serum-free
DMEM (Fig. 5E) was completely lost in the serum-
containing medium (Fig. 5F).
C
Fig. 6. Detection of intracellular plasmid DNA labeled with
ethidium monoazide (EMA). A HeLa cell hybrid, CGL1, was
transfected with EMA-labeled pGL-1 (1 Wg/ml) in 5% serum-
containing DMEM in the presence (A) or absence (B) of TFL-
08 liposome. Intracellular plasmid DNA labeled with EMA was
detected by confocal laser scanning microscopy.
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3.5. Relationship between the delivered plasmid and
transgene expression: detection of a
£uorescent-labeled DNA by confocal laser
microscopy
In the present study, the question arose as to how
e⁄ciently the TFL-08-mediated transgene expression
is controlled; the e⁄ciency was higher in a non-tu-
morigenic HeLa-cell hybrid CGL1 than in the tu-
morigenic counterpart, CGL4, and the transgene ex-
pression in CGL1 cells was stronger in serum-
containing medium than in serum-free medium.
These di¡erences could be partly ascribed to the pro-
cess of encapturation of the liposome^plasmid com-
plex by the cell. To test this, EMA, a £uorescent
intercalating probe, was used to label the GFP plas-
mid DNA covalently by photoactivation. This EMA-
labeled plasmid was detected within CGL1 cells by
confocal laser scanning microscopy under the condi-
tions in which TFL-08 mediated GFP expression,
but not the uninduced condition (Fig. 6). This detec-
tion also eliminated the EMA-labeled plasmid ad-
sorbed to the cell surface.
When this lipofection-dependent delivery of the
EMA-labeled plasmid into CGL1 cells was examined
quantitatively at given times during transfection, the
number of cells containing the labeled plasmid line-
arly increased up to 5^10 h, at which time about 80%
of the cell were labeled (Fig. 7A). It was also noted
that the labeled plasmid was mostly detectable in the
cytoplasm near the nucleus. These labeled plasmids
in CGL1 cells gradually disappeared with further in-
cubation, but it remained detectable in about 40% of
the cells at 24 h after transfection at which time the
level of the transgene expression was highest. In tu-
morigenic CGL4 cells, a similar incorporation of the
EMA-labeled plasmid was observed; the uptake pro-
cess was not impaired in these cells. However, the
labeled plasmid disappeared more rapidly and was
detectable only in 20% of CGL4 cells at 24 h after
transfection (Fig. 7A). A relatively rapid disappear-
ance of the labeled plasmid was also evident in
CGL1 cells when transfection was performed in se-
rum-free medium (Fig. 7B).
4. Discussion
Cationic liposome has proved to be an e¡ective
tool for gene delivery both in vitro and in vivo [1^
3,6]. Several clinical trials for gene therapy using cat-
ionic liposomes are ongoing with human genetic dis-
eases and cancer [17,18]. However, the factors that
control cationic liposome^DNA complex (CLDC)-
mediated gene transfer remain poorly understood,
and results have varied depending not only on the
formulation of the cationic liposome, but also on the
cell type. In addition, little is known about the mech-
Fig. 7. Changes in intracellular plasmid DNA. (A) CGL1 cells
were transfected with EMA-labeled plasmid+TFL-08 liposome
as described in Fig. 6 and the level of intracellular plasmid
DNA was determined at the indicated times after transfection
and was expressed as a percentage of the total cells : 200^300
CGL1 cells (continuous line) or CGL4 cells (broken line). (B)
A similar transfection experiment with CGL1 cells was per-
formed in the presence (continuous line) or absence (broken
line) of 5% serum.
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anism of this process, including the uptake as well as
targeting and stability of the complex within the
cells. Thus, clari¢cation of these factors as well as
the molecular events involved in CLDC-based gene
delivery are particularly important for regulating and
improving the e⁄ciency of gene therapy especially in
human diseases.
One of the major shortcomings of this non-viral
method of gene transfer is an inhibitory e¡ect of
serum [3,19^21]. Since serum contains various types
of charged molecules, their binding to CLDC may
modify its structural and physical characteristics,
rendering it sensitive to nucleases. In some formula-
tions containing a cationic lipid with spermine head-
groups [22], the presence of serum makes the CLDC
smaller with a reduced transgene activity. These facts
led us to search for an ideal formulation of liposome
in the complex form with good transgene expression
in serum-containing medium [9].
In the present study, on £ow cytometry of the
GFP gene transfer, we observed that a cationic lipo-
some termed TFL-08, whose formulation is DC-6^
14, DOPE and cholesterol in molar ratio 4:3:3,
showed fairly good e⁄ciency to transfer the GFP
gene into cultured human cell hybrids derived from
a human cervical carcinoma HeLa line in the pres-
ence of 5^10% fetal bovine serum. In contrast, in a
control experiment on transgene expression through
Lipofectamine, a well-known cationic liposome, the
transfection e⁄ciency was greatly reduced by 5^10%
serum (Fig. 4). As previously suggested, one of the
reasons for the lower transgene expression in serum-
containing medium may be the instability of the li-
posomal structures [22,23]. In another report, CLDC
is often heterogeneous with respect to size and shape,
which may in£uence transfection e⁄ciencies [24,25].
Studies on electron microscopy of TFL-08 liposome
demonstrated that the shape and size was homoge-
neous and the spherical structure was maintained
even in serum-containing medium (Fig. 5). In con-
trast, the globular structures of Lipofectamine rap-
idly disappeared in serum-containing medium. These
facts support that the stability of the spherical/glob-
ular structure of the liposome^DNA complex in se-
rum-containing medium is particularly important to
the transfection activity of cationic liposomes, which
would be potentially useful for in vivo human gene
therapy. Just how cholesterol relates to the structure
and function of this DC-6^14-liposome is unknown,
however, the e⁄ciency of gene expression through
DC-6^14 liposomes with di¡erent formulations
varies among cell types [9]. This issue is further in-
vestigated quantitatively.
The physicochemical properties, such as particle
sizes and surface charges of the liposome^DNA com-
plex may be also important factors to obtain a higher
transfection e⁄ciency of the liposomal vectors. For
1 Wg of plasmid DNA which has about 3 nmol of
negative charged molecules, 6^8 nmol TFL-08 lipo-
some containing 2.4^3.2 nmol of cationic lipid (DC-
6^14) was e¡ective to deliver the GFP gene into cells
(Fig. 3). The estimated charge ratio of DNA^lipo-
some complex might be within the ranges of 1:1
under the optimal conditions, suggesting that a neu-
tralized surface charge of the liposome^DNA com-
plex is mostly useful for the in vitro gene transfer,
although the charged complex both positively and
negatively would also be e¡ective, as described with
other cationic liposomes [26,27]. Further studies on
the physicochemical properties of TFL-08 liposome^
DNA complex and its interaction with cell mem-
branes in serum-containing medium are in progress.
In a non-tumorigenic HeLa cell hybrid, CGL1, the
transfection e⁄ciency of TFL-08 liposome was about
50% in serum-containing medium, while in a tumori-
genic cell hybrid, CGL4, it was less than 10% in the
presence and absence of serum (Fig. 3). This decrease
in e⁄ciency may not simply re£ect a lower transfec-
tion ability of this liposome for tumorigenic human
cells, since TFL-08 could transfer genes into several
other human tumor cells (unpublished results). Thus,
the lower TFL-08-mediated gene expression in tu-
morigenic HeLa cell hybrids may be associated
with the characteristics controlled by a putative tu-
mor suppressor gene [10^12].
To examine the di¡erence in transfection e⁄ciency
of TFL-08 between HeLa cell hybrids, the plasmid,
photolabeled with EMA and transferred along with
liposome into the cells, was quantitatively analyzed
by confocal laser microscopy. The percentage of cells
containing the labeled plasmid linearly increased
with the incubation period, reaching about 80%
both for CGL1 and CGL4 cells at 8^12 h after trans-
fection (Fig. 7A). Therefore the transfer of the la-
beled plasmid into these cell hybrids were similarly
enhanced by TFL-08 liposome. The labeled plasmid
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was detected in about 40% of cells even after 24 h in
the CGL1 cells, whereas in CGL4, which showed a
transgene expression as low as 10%, the percentage
of EMA-positive cells more rapidly decreased from
the peak level and was about 20% at 24 h after trans-
fection. A weaker transgene expression in CGL1 cells
in serum-free medium seemed to be consistent with
this rapid diminution of the EMA-labeled plasmid
(Fig. 7B). These results suggest that the stability of
the transferred plasmid within the cells is crucial to
the strength and duration of transgene expression
and the di¡erence in transfection e⁄ciency between
these HeLa cell hybrids with TFL-08 liposome may
be at least partly ascribed to the stability of the plas-
mid in the cells. Recently, the importance of stability
in liposome-mediated transgene expression in vivo
has also been documented [27].
The transgene seems to degrade in lysosomes or
endosomes and this is a common problem when cat-
ionic liposomes are used [2,28]. DOPE, a component
of TFL-08 liposome, has acted as a helper lipid in
various types of liposomes for gene transfection
[23,24], although none contained cholesterol. DOPE
has been reported to show a strong tendency to form
an inverted hexagonal structure at acidic pH and this
formation induced by DOPE probably destabilizes
endosomes/lysosomes, resulting in escape from lyso-
somal degradation and cytoplasmic release of the
transgene [7,23]. Although it remains unknown
whether the e⁄ciency of transgene expression by
TFL-08 with serum is directly linked to its stability
and the formation of inverted hexagons in lysosomes
or endosomes, the present results suggest that a
strong, stable expression of the transgene in the tar-
get cells is obtained with this new formulation of
cationic liposome. Further studies on molecular
events underlying transgene expression with these
novel cationic liposomes should improve an attrac-
tive vehicle for gene delivery to human cells.
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